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Sodium leak through K2P potassium
channels and cardiac arrhythmia, an
emerging theme
Steve AN Goldstein
In this issue of EMBO Molecular Medicine,
Decher et al (2017) identify a point muta-
tion in the K2P2 (TREK-1) potassium (K+)
channel that changes function in just
those ways expected to predispose to
right ventricular outflow tract (RVOT)
ventricular tachycardia (VT) in the patient
they study. Whereas wild-type channels
are selective for K+ and inhibited by
b-adrenergic stimulation, mutant I267T
channels pass sodium (Na+) into the cells,
even during b-adrenergic stimulation, and
are more active in response to membrane
stretch, changes predicted to enhance
cardiac myocyte excitability. The report
contributes to accumulating evidence for
Na+ leak via K2P channels in association
with normal development (Thomas et al,
2008), acquired arrhythmia (Ma et al,
2011), and now a missense mutation.
Decher et al (2017) both inform and direct
us toward interesting opportunities for
further investigation.
See also: N Decher et al (April 2017)
E ach normal heartbeat results from anaction potential (AP) wave that beginsin the cardiac atria and travels to the
ventricles, causing the chambers to contract
and pump blood (Fig 1A). Whereas most
changes in the rate or rhythm of heartbeats
(arrhythmia) can be well tolerated, VT can
lead to hemodynamic compromise if the
heart cannot supply enough blood to the
body (Fig 1B and C), a particular risk if
the abnormal rhythm is sustained or
degenerates to ventricular fibrillation. Like
10% of patients with VT of unknown cause
(idiopathic), the patient in this study has no
structural heart disease, no metabolic or
electrolyte abnormalities, and no other
mutations known to cause arrhythmia.
About 70% of idiopathic VT begins in the
RVOT. While the prognosis for RVOT-VT is
generally excellent, sudden death can occur
and periodic follow-up is important to rule
out latent, progressive arrhythmogenic right
ventricular cardiomyopathy (Noda et al,
2005). If symptoms or family history argue
for treatment, patients respond well to phar-
macotherapy or ablation of the RVOT site
producing the aberrant electrical signals via
a catheter threaded into the heart through a
vein. The disorder usually presents between
30 and 50 years (range 6–80), hormonal
influences are seen in premenopausal
women, and episodes are often triggered by
sympathetic stimulation (for example, anxi-
ety, excitement, or caffeine).
Decher et al (2017) employed a candidate
gene approach to identify the mutation and
then judged its potential to cause disease by
studying its frequency in the population and
its impact on channel function. Sequencing
KCNK2, the gene for K2P2, in 438 patients
with idiopathic arrhythmia yielded one
patient among the 40 with a diagnosis of
RVOT-VT who was heterozygous for I267T,
carrying one wild-type (WT) gene and one
mutant allele. Consistent with a role in
disease causation, the change was not seen
in 379 controls; it was present in 3 of 13,003
alleles in the Exome Variant Server data-
base; in 388 other genes the patient showed
variations judged to be neutral by a suite of
pathogenicity prediction tools; and I267T
was in a noteworthy location, the second
pore loop (P) domain of the K2P2 subunit.
Each K2P channel subunit has two pore
(P) loop domains, hence the K2P nomencla-
ture (Fig 1D) (Plant et al, 2017). A complete
K2P channel has two subunits that create
one membrane-spanning ion conduction
pore lined by four P loop domains on the
central axis of symmetry (Brohawn et al,
2012). Seeking to recapitulate the three
K2P2 channels expected to form in the
patient (channels with two WT subunits,
two I267T subunits, or one of each type,
Fig 1E), the authors injected cRNAs into frog
oocytes to express the subunits for electro-
physiology studies.
The effects of I267T were dramatic. Cells
with I267T were different in two key ways
from those with only WT channels: net
outward currents were decreased and the
resting membrane potential (RMP) of the
cells more depolarized (positive). Both find-
ings result from inward Na+ leak through
mutant channels. The WT channels passed
outward currents because they conducted
K+ in preference to Na+ and the electro-
chemical driving force favors efflux of
K+ down its concentration gradient
(K+in ~140 mM versus K
+
out ~5 mM)
during the cardiac cycle—this is a restoring
current that hyperpolarizes the cells toward
RMP. In contrast, cells with I267T passed
Na+ inward, down its concentration
gradient (Na+out ~135 mM versus
Na+in ~10 mM), decreasing the net outward
current—an excitatory effect. Moreover,
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the RMP is set by the relative permeability
of ions across the plasma membrane, so
excess Na+ influx caused an excitatory
depolarization in the resting set point. In a
nice experimental turn, they showed that
the magnitude of K+ efflux was the same
through WT and I267T channels in the
absence of external Na+; this indicated that
the mutation did not alter the synthesis,
assembly, trafficking, or half-life of the chan-
nels as a basis for decreased outward
current in the oocytes. Unexpectedly, they
found I267T channels both resisted b-adre-
nergic suppression, allowing Na+ leak to
persist, and to be more sensitive to activa-
tion by membrane stretch than WT.
Each of these effects of I267T is expected
to be pro-arrhythmic in vivo. Indeed, they
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Figure 1. Molecular cardiology of RVOT-VT: anatomy, electrophysiology, and the structure and function of K2P2.
(A) The chambers of the heart and conduction system. Venous blood flows back from the body to the right atrium (RA), is pumped to the right ventricle (RV), and then out
through the RVOT (*) into the pulmonary arteries (PA) to the lungs. Oxygenated blood returns to the left atrium (LA), is pumped to the left ventricle (LV), and then out the aorta
(Ao) to the body. The conduction system is indicated in silver: excitation begins in the sinoatrial node atop the RA, travels down to the atrioventricular node, and after a brief
delay, travels the Purkinje fiber system to excite the ventricles. (B) Normal sinus rhythm and the ventricular AP. Top: surface ECG (lead II) shows the P wave associated with
atrial excitation, the QRS reflecting ventricular activation, and the T wave showing ventricular repolarization. The rapid rise in the membrane potential is due to SCN5A (INa)
and repolarization is due to K+ flux via IKs, IKr, and K2P channels (currents not to scale). (C) Monomorphic VT on a surface ECG. Rapid, repetitive excitations from an abnormal
ventricular locus (lead II); the full 12-lead ECG shows LBBB and an inferior axis, common for RVOT-VT. (D) K2P subunit topology and channel structure. Top: One K2P subunit
has four transmembrane segments, two P loop domains, and intracellular N and C termini; I267T in the second P loop domain is indicated (*). Middle: Ribbon representation of
K2P4 with the first P domain in blue, the second in orange, and K+ ions as green spheres with membrane boundaries suggested by gray bars, by permission (Brohawn et al,
2012). Bottom: A view from the cytoplasm. (E) Three types of K2P2 channels in the patient. One wild-type (WT) gene and one for I267T is predicted to yield channels with two
WT subunits, two I267T subunits (the second P domain is now pink), or one of each. The WT channels pass K+ outward. Decher et al (2017) show that channels with two I267T
subunits pass inward Na+; the drawing shows channels with two altered residues, one on each I267T subunit and mixed channels with one altered residue (shown passing
Na+ but this has not yet been demonstrated).
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found that overexpression of I267T in
human atrial tumor cells depolarized the
RMP, increased the rate of spontaneous
beating, and slowed the AP upstroke veloc-
ity (a parameter known to contribute to
ventricular re-entry arrhythmias), compared
to WT. As an encouraging first step toward
mechanistically inspired therapy, BL-1249, a
fenamate compound, restored K+ selectivity
to cells expressing the mutant channels.
The human heart beats ~100,000 times
every day, even in patients predisposed to
arrhythmia. In such a resilient system, is it
reasonable to ascribe RVOT-VT to leaky K2P
channels? Studies of SCN5a and long QT
syndrome (LQTS type 3) suggest this is a
sensible hypothesis (Belardinelli et al, 2015;
Bohnen et al, 2017). Each AP results from a
delicate orchestration of ion fluxes (Fig 1B).
In the ventricles, the AP begins when the
membrane reaches a threshold potential and
SCN5a voltage-gated Na+ channels open to
produce an explosive influx of Na+ current
(INa) leading cells to depolarize. SCN5a
channels inactive rapidly, influx of calcium
maintains the AP plateau, and the AP ends
due to K+ efflux through depolarization-acti-
vated IKr and IKs channels. Mutations that
produce a small excess of INa through SCN5a
channels can seriously disrupt cardiac elec-
trophysiology, prolonging the AP duration,
slowing repolarization and, in some cases,
increasing cytosolic Na+ sufficiently to drive
pumps to increase intracellular calcium, all
effects that are pro-arrhythmic. Thus,
changes that render SCN5a inactivation slow
or incomplete and increase INa late in the AP
from ~0.3–1% of peak current are sufficient
to predispose to VT, Torsade de pointe, and
sudden death. The fine balance of currents
is apparent: the small late Na+ current
passed by SCN5a under normal conditions is
similar in size but opposite in direction to
IKs in guinea pig ventricle.
Other channels, including K2P channels,
also contribute to the AP, modifying its
shape differentially in the atria, conduction
pathways, ventricles, and across the
myocardial wall. While the magnitude of
K2P2 K+ current in human heart cells is
unknown, the absence of a prolonged QT in
the patient suggests the magnitude of Na+
flux via I267T channels in ventricular cells is
less than INa late. This suggests I267T imbal-
ances activating and restoring currents
locally in the RVOT perhaps due to
increased sensitivity of I267T to membrane
stretch, a pro-arrhythmic stimulus even
under wild-type conditions. Also consistent
with a mechanism involving decreased repo-
larization reserve, as seen with excess
inward Na+ current, K+ channel expression
is regulated by sex and stress hormones.
Humans have 15 genes for K2P channels
(Plant et al, 2017). Identified based on their
unique subunit architecture (Ketchum et al,
1995; Lesage et al, 1996) as well as their
functional attributes (Goldstein et al, 1996),
understanding their roles in physiology is a
work in process. Operating across the body
as homodimers and heterodimers, K2P chan-
nels are responsible for many of the regu-
lated background currents essential to nerve
and muscle function because they are open
across the physiological voltage range, pass-
ing outward K+ currents that help set RMP
and repolarize the membrane below firing
threshold after excitation. It seems logical
then that changing the selectivity of cardiac
K2P2 channels could impact tissue excitabil-
ity. While K2P2 is highly expressed in the
human brain and endocrine system, tran-
scripts are present in the heart accompanied
by those for K2P1, K2P3, K2P5, K2P15, and
K2P17. Two prior studies seem particularly
germane.
We observed a natural structural change
in K2P2 that allows it to conduct Na+
(Thomas et al, 2008). Thus, K2P2 protein and
a variant lacking 56 N-terminal residues due
to alternative translation initiation (K2P2Δ56)
are expressed at different levels in different
regions of the rat CNS in a manner that
changes during development. Whereas K2P2
is selective for K+, the short version conducts
Na+ and, similar to I267T, this leads to a
depolarized RMP. Thus, Na+ flux through
K2P2Δ56 appears to have normal roles in the
rat brain during maturation and adult func-
tion. Of note, Decher et al (2017) suggest an
explanation for a discrepancy in the literature;
a group that did not observe Na+ flux via
K2P2Δ56 channels had fenamates (including
BL-1249), that restore K+ selectivity to I267T
channels, in their solutions.
Ma et al (2011) observed Na+ flux via
the K2P1 (TWIK-1) channel. Whereas I267T
and K2P2Δ56 channels show stable changes
in ion selectivity, WT K2P1 channels alter
their permeation attributes reversibly, allow-
ing Na+ to pass when exposed to the low
extracellular levels of K+ present in the
serum of patients with hypokalemia. Na+
influx via K2P1 appears to explain arrhyth-
mia-associated “paradoxical depolarization”
that is detected in a subset of cardiac
myocytes: whereas lowering serum K+
would be expected to increase driving force
for K+ efflux and lead to membrane hyper-
polarization, K2P1 channels lose their pref-
erence for K+ allowing Na+ influx and
depolarization. The selectivity of classical
K+ channels formed by subunits with one P
domain appears to be stable under physio-
logical conditions. In contrast, K2P1 and
K2P2 are now seen to loosen their restriction
against Na+ permeation under both natural
and disease-associated conditions. Perhaps,
other K2P channels will follow suit.
The findings by Decher et al (2017) have
begun the process of correlating genotype
and phenotype. As each journey begins with
a step, they identify one patient with I267T.
More patients must be studied to verify the
association with RVOT-VT, and this sentinel
case will stimulate that valuable inquiry.
Other open questions will thereby be
addressed: does I267T act alone or is it
linked to changes in other genes or the vast
non-coding regions of the genome? What is
the role of ethnic context? Are other variants
of KCNK2 pro-arrhythmic? How do epige-
netic influences impact disease penetrance?
Do mutations in other genes alter ion selec-
tivity (stably or in response to environmen-
tal perturbations) to produce arrhythmia?
We molecular cardiologists employ
model systems to assess function but none
recapitulates the human heart or its cells
with fidelity. Decher et al (2017) employ
heterologous overexpression and modeling
to achieve detailed biophysical characteriza-
tion of I267T but elevated channel levels
and non-natural cellular milieus are limita-
tions. Open questions therefore include
where, when, and with what partners does
K2P2 operate in the human heart (a conun-
drum for channels that have been studied
for decades longer)? Does K2P2 act similarly
in myocytes at low natural levels? Does
I267T in the brain influence cardiac func-
tion? An approach to some of these issues is
suggested by rapid advances in CRISPR-Cas9
technology: expressing I267T from the
native K2P2 locus might reveal susceptibility
to RVOT-VT in an animal, show native
Na+ influx, membrane depolarization, and
calcium overload in cardiomyocytes, and
permit appraisal of fenamates as drug leads.
Decher and colleagues increase our
understanding of normal cardiac physiology,
the operation of K2P channels, and the
pathophysiology of RVOT-VT. The work is a
step toward transforming an idiopathic
ª 2017 The Author EMBO Molecular Medicine Vol 9 | No 4 | 2017
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syndrome into defined disorders with
explicit causality. Actualization of this
aspect of precision medicine will improve
evidence-based interventions and serve as
the basis for risk stratification. This is partic-
ularly important for unpredictable, multifac-
torial disorders like episodic arrhythmias
where genetic variation predisposes to
events that are infrequent. Thus, genomic
sequencing may someday flag a person with
a K2P Na+ leak variant, and indicate if she
is likely to respond to a BL1249 derivative,
before experiencing a frightening arrhyth-
mia. More urgently, this type of linkage may
inform physicians when it is critical to inter-
vene. Rare patients who die suddenly with a
diagnosis of RVOT-VT do not present dif-
ferently than the large majority who have a
benign outcome and, yet, an aggressive
approach to all patients is ill advised
because RVOT-VT is common and therapies
carry their own risks (Noda et al, 2005).
Thus, studies of cells, animals, and patients
to validate the linkage of I267T and RVOT-
VT, identify other changes that predispose to
RVOT-VT, and place the role of abnormal
Na+ flux into a diagnostic and therapeutic
context will build on this elegant work to
advance the frontiers of molecular medicine.
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